On February 25, 2020 Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for autoimmune/inflammatory diseases and cancer, reported the company will present at two upcoming investor healthcare conferences in March (Press release, Alpine Immune Sciences, FEB 25, 2020, View Source [SID1234554718]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 40th Annual Healthcare Conference
Tuesday, March 3, 2020 at 11:20 a.m. Eastern Time in Boston, MA

Oppenheimer & Co. 30th Annual Healthcare Conference
Tuesday, March 17, 2020, at 4:30 p.m. Eastern Time in New York, NY

A live webcast of each presentation will be available online by visiting the investor relations page of the Company’s website, at View Source An archive of each webcast will be available on the Company’s website for 30 days.